| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4125467 | Otolaryngology - Head and Neck Surgery | 2009 | 6 Pages |
Abstract
The present results suggest that MVD evaluation with CD105 is a promising prognostic factor for the outcome of patients with laryngeal SCC. CD105-assessed MVD could help to identify patients with more aggressive disease and increased risk of developing malignancy recurrence after treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Elvir MD, MSc, Anton MD, PhD, Ljiljana MD, PhD, Vojko MD, PhD, Milan MD, PhD,